67457-325-12 : NDC 2026 Code

67457-325-12 : Bendamustine Hydrochloride ( Bendamustine Hydrochloride )

Additionally :

You can get information about “67457-325-12” NDC code in 67457-325-12 in HTML format

HTML | 67457-325-12 in TXT (Plain Text) format

TXT | 67457-325-12 in PDF (Portable Document Format)

PDF | 67457-325-12 in XML format

XML formats.

NDC Code : 67457-325-12 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "67457-325-12",
    "PackageDescription": "5 mL in 1 VIAL, SINGLE-DOSE (67457-325-12) ",
    "NDC11Code": "67457-0325-12",
    "ProductNDC": "67457-325",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Bendamustine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bendamustine Hydrochloride",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20180426",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA204104",
    "LabelerName": "Mylan Institutional LLC",
    "SubstanceName": "BENDAMUSTINE HYDROCHLORIDE",
    "StrengthNumber": "25",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Alkylating Activity [MoA],Alkylating Drug [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2019-02-23",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20191231",
    "StartMarketingDatePackage": "20180426",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}